Endacea
Locations
Research Triangle Park, Durham, NC, USA
Endacea develops A1 adenosine receptor antagonists as drug candidates for acute lung injury, sepsis and acute renal failure. Endacea is also developing a novel immunotherapy, mutant plasmid cDNA for the A1 adenosine receptor, for cancer.
Something looks off?Open jobs at Endacea
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.